Individualize Duration of Dual Antiplatelet Therapy in Stent Patients
February 2022
You’ll see more of a shift to SHORTER courses of dual antiplatelet therapy (DAPT) after a coronary stent in stable ischemic heart disease.
Individualize the duration of aspirin PLUS another antiplatelet (clopidogrel, etc) based on ischemic and bleeding risks.
Most evidence is with 6 months of DAPT in these stable patients who get a drug-eluting stent.
Generally stick with this approach if ischemic risk is high due to smoking, prior stent thrombosis, etc. Then switch to aspirin 81 mg/day alone indefinitely.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote